PFIZER INC

Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 22,032,040 shares
Security Ownership %: 9%

Shares, Excluding Options vs Price

Value, Excluding Options

Pfizer Inc. ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

13 Feb 2026 - Pfizer Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 22,032,040 shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 9% ownership of the company. This is the first filing by PFIZER INC disclosing ownership of Allogene Therapeutics, Inc. Common Stock (ALLO).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Pfizer Inc.	9%		$30,183,895	22,032,040			$1.37	13D/A	06 Nov 2025	13 Feb 2026, 17:09

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	13%	0%	$30,183,895	22,032,040	$1.37	Q4 2025
30 Sep 2025	6.2%	0%	$27,319,730	22,032,040	$1.24	Q3 2025
30 Jun 2025	4.3%	0%	$24,896,205	22,032,040	$1.13	Q2 2025
31 Mar 2025	6.4%	0%	$32,166,778	22,032,040	$1.46	Q1 2025
31 Dec 2024	1.8%	0%	$46,928,245	22,032,040	$2.13	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.